| Literature DB >> 31075984 |
Manuel M Romero-Ruiz1, Francisco Javier Gil-Mur2, José Vicente Ríos-Santos3, Pedro Lázaro-Calvo4, Blanca Ríos-Carrasco5, Mariano Herrero-Climent6.
Abstract
PURPOSE: The objective of this study was to assess the influence of a novel surface of dental implants (ContacTi®) on the osseointegration process in a minipig model. The surface was compared with other existing surfaces on the market (SLA® and SLActive®) by employing bone implant contact analysis (BIC) and implant stability.Entities:
Keywords: Bioactive Implants; Histomorfometric analytic; Implant surface; Oral implants; minipigs
Mesh:
Substances:
Year: 2019 PMID: 31075984 PMCID: PMC6539430 DOI: 10.3390/ijms20092307
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Representative histological images of the three surfaces (ContacTi®, SLA = SLA®, SLAct = SLActive®) in the jaw at the different time points of the study (2, 4, and 8 weeks). Magnification 75×.
Figure 2Histological images of the ContacTi® and SLActive® surfaces obtained by SEM in a maxillary section at 8 weeks, at 150× magnification.
Relative means of the ISQ value in the measurements performed in group 1 (euthanasia at 2 weeks), both on the day of surgery (ISQ SURG) and at the time of euthanasia (ISQ EUT), for each of the three groups.
| GROUP 1 | ISQ SURG | ISQ EUT | ||
|---|---|---|---|---|
|
| Mean ± SD |
| Mean ± SD | |
| SLA® | 4 | 81.25 ± 5.12 | 3 | 81.67 ± 5.77 |
| SLActive® | 4 | 69.25 ± 13.35 | 4 | 77.25 ± 5.85 |
| ContacTi® | 3 | 65.33 ± 7.77 | 3 | 77.00 ± 2.00 |
|
| 0.124 | 0.467 | ||
surg = surgery; SD = standard deviation; eut = euthanasia.
Relative means of the ISQ value in the measurements performed in group 2 (euthanasia at 4 weeks), both on the day of surgery (ISQ SURG) and at the time of euthanasia (ISQ EUT), for each of the three groups. The lowercase letters show in standard form (columns) the differences in pairs between the means by the Tukey method after detecting statistical significance in the ANOVA.
| GROUP 2 | ISQ SURG | ISQ EUT | ||
|---|---|---|---|---|
|
| Mean ± SD |
| Mean ± SD | |
| SLA® | 4 | 68.00B ± 4.69 | 2 | 81.00a ± 1.41 |
| SLActive® | 4 | 76.00 ± 9.49 | 3 | 78.67ab ± 4.16 |
| ContacTi® | 4 | 71.25 ± 4.72 | 4 | 72.50bB ± 2.38 |
|
| 0.285 | 0.030 | ||
surg = surgery; SD = standard deviation; eut = euthanasia.
Relative means of the ISQ value in the measurements performed in group 2 (euthanasia at 8 weeks), both on the day of surgery (ISQ SURG) and at the time of euthanasia (ISQ-TSU), for each of the three groups. The lowercase letters show in standard form (columns) the differences in pairs between the means by the Tukey method after detecting statistical significance in the ANOVA.
| GROUP 3 | ISQ SURG | ISQ EUT | ||
|---|---|---|---|---|
|
| Mean ± SD |
| Mean ± SD | |
| SLA® | 4 | 79.25A ± 3.77 | 3 | 81.67a ± 4.04 |
| SLActive® | 4 | 78.50 ± 2.65 | 4 | 80.50a ± 3.70 |
| ContacTi® | 4 | 75.25 ± 3.10 | 4 | 73.50bAB ± 1.29 |
|
| 0.226 | 0.015 | ||
surg = surgery; SD = standard deviation; eut = euthanasia.
Figure 3Boxplot for comparison of the ISQ SURG and ISQ EUT values by surface studied throughout the different time points of the study.
Mean %BIC values at different points in the study and the absolute means.
| BIC (%) | Group 1: | Group 2: | Group 3: |
| |||
|---|---|---|---|---|---|---|---|
|
| Mean ± SD |
| Mean ± SD |
| Mean ± SD | ||
| SLA® | 8 | 53.56B ± 19.96 | 6 | 81.60A ± 13.31 | 8 | 77.99bA ± 6.89 | 0.003 |
| SLActive® | 8 | 61.56B ± 13.39 | 8 | 85.36A ± 13.98 | 8 | 87.18aA ± 4.93 | <0.001 |
| ContacTi® | 6 | 62.35B ± 20.01 | 8 | 88.25A ± 17.67 | 8 | 90.0258abA ± 9.90 | <0.001 |
|
| 0.493 | 0.847 | 0.020 | ||||
EUT = euthanasia; SD = Standard deviation; a, b—different letters indicate significantly different means between different surface treatments according to the DMS test; A, B—different letters indicate significantly different means between groups according to the Tukey HSD test.).
Figure 4Mean values of the bone-implant contact, BIC (%), for the three surfaces at the different time points in the study. With the box diagram are determined the outliers (circle) that go out of the standard (extreme values).
Correlation between ISQEut and BIC, and between ISQEut and BAT for each implant system (surface) and time (group).
| G1: 2 Weeks | G2: 4 Weeks | G3: 8 Weeks | G1: 2 Weeks | G2: 4 Weeks | G3: 8 Weeks | ||
|---|---|---|---|---|---|---|---|
| Surface | ISQ Eut vs. BIC (%) | ISQ Eut vs. BAT (%) | |||||
| SLA® | Spearman’s rho | 0.828 | 0.943 | 0.000 | 0.828 | 0.894 | −0.621 |
|
| 0.052 | 0.057 | 1.000 | 0.052 | 0.106 | 0.188 | |
|
| 6 | 4 | 6 | 6 | 4 | 6 | |
| SLActive® | Spearman’s rho | 0.683 | 0.956 | −0.146 | 0.634 | −0.598 | −0.537 |
|
| 0.062 | 0.053 | 0.729 | 0.091 | 0.210 | 0.170 | |
|
| 8 | 6 | 8 | 8 | 6 | 8 | |
| ContacTi® | Spearman’s rho | −0.717 | −0.206 | 0.244 | −0.478 | −0.466 | −0.098 |
|
| 0.109 | 0.625 | 0.560 | 0.338 | 0.245 | 0.818 | |
|
| 6 | 8 | 8 | 6 | 8 | 8 | |